	US 12,344,620 B2
	BRD4 inhibitor compound in solid form and preparation method therefor and use thereof
Chunli Shen, Shanghai (CN); Yong Liu, Shanghai (CN); Huanyu Bian, Shanghai (CN); Chengde Wu, Shanghai (CN); and Jiahu Wu, Shanghai (CN)
Assigned to CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD., Shijiazhuang (CN)
Appl. No. 17/593,668
Filed by CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD., Shijiazhuang (CN)
PCT Filed Mar. 23, 2020, PCT No. PCT/CN2020/080741 § 371(c)(1), (2) Date Sep. 22, 2021, PCT Pub. No. WO2020/192637, PCT Pub. Date Oct. 1, 2020.
Claims priority of application No. 201910225039.6 (CN), filed on Mar. 22, 2019.
Prior Publication US 2022/0185820 A1, Jun. 16, 2022
Int. Cl. C07D 495/14 (2006.01)

CPC C07D 495/14 (2013.01) [C07B 2200/13 (2013.01)]

15 Claims

1. A compound of formula (I) in crystal form,